The medical device export business in India is gaining serious traction in 2026. With strong government support through the PLI scheme, improving regulatory efficiency via the Sugam portal, and steady demand from U.S. buyers seeking cost-effective and reliable supply chains, many manufacturers and entrepreneurs are actively exploring this space. Getting the licenses for exporting medical devices, preparing the right documents required for medical device export, and building a profitable medical device export process are the three pillars that separate successful operations from those that struggle with delays or rejected shipments.
India exported around $4.1 billion in medical devices in FY25, with the broader sector targeting significant growth toward $50 billion by 2030. American hospitals, distributors, and group purchasing organizations benefit directly from Indian manufacturing strengths in disposables, surgical instruments, and select diagnostic categories. For U.S. readers, diversified sourcing from India helps control costs and strengthens supply resilience amid global uncertainties.
Here’s what you need to know to run a compliant and profitable export operation in 2026.
Essential Licenses for Medical Device Export Business in India
Every serious exporter must secure these foundational approvals:
- Import Export Code (IEC): Mandatory from the Directorate General of Foreign Trade (DGFT). This is your basic export license and can be obtained online relatively quickly.
- CDSCO Manufacturing License: Issued under the Medical Device Rules, 2017. The exact form and pathway depend on your device classification (Class A–D). Lower-risk devices often go through State Licensing Authorities, while higher-risk devices require deeper Central Drugs Standard Control Organization (CDSCO) review. A valid manufacturing license is critical for credibility with international buyers.
- GST Registration: Required for invoicing, input tax credit, and smooth domestic operations that support exports.
- ISO 13485 Certification: Not a government license but often treated as essential by buyers. It proves your quality management system meets global standards for medical devices.
For certain products or novel devices, you may also need to verify Export NOC requirements through CDSCO’s Sugam portal. While more common for pharmaceuticals, confirming this early prevents last-minute shipment holds.
Key Documents You Must Prepare
Strong documentation protects both compliance and cash flow. Core documents include:
- Device Master File (DMF) and Plant Master File (PMF) — These detail your product design, manufacturing processes, and facility controls.
- Technical File / Design Dossier — Includes risk management (aligned with ISO 14971), clinical or performance evaluation data, and labeling information.
- Free Sale Certificate (FSC) — Issued by CDSCO when applicable; shows the device is legally marketable in India or manufactured to equivalent standards.
- Quality and Test Certificates — ISO 13485, batch test reports, and any destination-specific certifications.
- Commercial Export Documents — Commercial invoice, packing list, certificate of origin, bill of lading/airway bill, and insurance documents.
U.S.-bound shipments additionally require alignment with FDA expectations (establishment registration, device listing, and support for 510(k) or PMA filings usually handled by your American partner). Incomplete files are one of the biggest profit killers because they cause shipment delays and extra storage costs.
Building a Profitable Medical Device Export Process
Licenses and documents are non-negotiable, but profitability comes from smart execution:
Choose the right products first. Disposables, consumables (gloves, syringes, catheters, wound care), and basic surgical instruments offer faster regulatory pathways, quicker inventory turnover, and solid margins. High-end imaging or implantable devices deliver higher value but require heavier investment in clinical data and longer approval timelines.
Prioritize compliance to protect margins. Regulatory rejections or FDA warning letters destroy profitability. Invest upfront in robust quality systems and experienced regulatory consultants for your first few shipments. Many successful exporters start with lower-risk products to build a clean track record before scaling to complex devices.
Leverage the PLI scheme. The Production Linked Incentive program for medical devices offers financial incentives on incremental sales for eligible high-value products. This directly improves your landed cost competitiveness for U.S. buyers.
Partner strategically for the U.S. market. Most Indian manufacturers work with established U.S. importers or distributors who manage FDA 510(k) submissions and local regulatory responsibilities. This model reduces your direct compliance burden while giving American partners reliable, cost-competitive supply.
Optimize operations and logistics. Locate production in established medical device clusters for better supplier ecosystems. Use experienced freight forwarders familiar with regulated medical goods. Monitor landed costs closely (product + compliance + shipping + duties) and maintain healthy margins even after currency fluctuations.
Focus on long-term relationships. Repeat orders and volume commitments from U.S. hospitals or distributors are far more profitable than one-off transactions. Consistent quality, transparent communication, and reliable delivery timelines build the trust that drives sustainable growth.
Manufacturers and exporters who treat licensing, documentation, and quality as core business functions — rather than administrative hurdles — are the ones seeing steady profits in 2026. The India-U.S. medical device trade corridor continues to expand, offering real opportunities for those who prepare properly.
Follow us on X @realnewshubs and subscribe for push notifications